Skip to main content
. Author manuscript; available in PMC: 2014 Sep 15.
Published in final edited form as: Cochrane Database Syst Rev. 2004;(3):CD003331. doi: 10.1002/14651858.CD003331.pub2

Comparison 2. Subgroup analyses.

Outcome or subgroup title No. of studies No. of participants Statistical method Effect size
1 VO2 max (ml/kg/min) 24 4191 Mean Difference (IV, Random, 95% CI) −2.19[−2.48,−1.90]
 1.1 “Dose” of intervention =/> 30 units 11 432 Mean Difference (IV, Random, 95% CI) −2.78[−3.88,−1.69]
 1.2 “Dose” of intervention < 30 units 13 416 Mean Difference (IV, Random, 95% CI) −1.64[−2.15,−1.12]
 1.3 Jadad score = 3 and above 7 341 Mean Difference (IV, Random, 95% CI) −2.01[−2.90,−1.12]
 1.4 Jadad score = 2 and below 15 458 Mean Difference (IV, Random, 95% CI) −2.28[−3.47,−1.10]
 1.5 Duration of intervention >12 weeks 10 420 Mean Difference (IV, Random, 95% CI) −2.62[−3.76,−1.48]
 1.6 Duration of intervention =/<12 weeks 14 428 Mean Difference (IV, Random, 95% CI) −1.79[−2.33,−1.24]
 1.7 Mean age > 55 years 15 540 Mean Difference (IV, Random, 95% CI) −1.77[−2.50,−1.03]
 1.8 Mean age =/< 55 years 9 308 Mean Difference (IV, Random, 95% CI) −2.95[−4.25,−1.64]
 1.9 Duration of follow up > 16 weeks 9 397 Mean Difference (IV, Random, 95% CI) −2.74[−3.83,−1.65]
 1.10 Duration of follow up =/< 16 weeks 15 451 Mean Difference (IV, Random, 95% CI) −1.55[−2.17,−0.94]